Broad-Spectrum Antivirals Derived from Natural Products

Viruses. 2023 Apr 30;15(5):1100. doi: 10.3390/v15051100.

Abstract

Scientific advances have led to the development and production of numerous vaccines and antiviral drugs, but viruses, including re-emerging and emerging viruses, such as SARS-CoV-2, remain a major threat to human health. Many antiviral agents are rarely used in clinical treatment, however, because of their inefficacy and resistance. The toxicity of natural products may be lower, and some natural products have multiple targets, which means less resistance. Therefore, natural products may be an effective means to solve virus infection in the future. New techniques and ideas are currently being developed for the design and screening of antiviral drugs thanks to recent revelations about virus replication mechanisms and the advancement of molecular docking technology. This review will summarize recently discovered antiviral drugs, mechanisms of action, and screening and design strategies for novel antiviral agents.

Keywords: antiviral agents; direct-acting antivirals; host-targeting antivirals; natural products.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use
  • Biological Products* / pharmacology
  • COVID-19*
  • Humans
  • Molecular Docking Simulation
  • SARS-CoV-2
  • Virus Replication

Substances

  • Antiviral Agents
  • Biological Products

Grants and funding

This work was supported by the National Natural Science Foundation of China (32172821) and a CAU Grant for the Prevention and Control of Immunosuppressive Disease in Animals of the China Agricultural University.